A mutation in the iron-responsive element of ALAS2 is a modifier of disease severity in a patient suffering from CLPX associated erythropoietic protoporphyria
暂无分享,去创建一个
S. Ducamp | L. Gouya | H. Puy | Sara Luscieti | Mayka Sánchez | H. Manceau | Yvette Y. Yien | G. Nicolas | C. Kannengiesser | K. Peoc’h | X. Ferrer-Cortès